Search results
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO...
Benzinga via Yahoo Finance· 4 hours agoCoya Therapeutics Inc (NASDAQ:COYA) is a clinical-stage biotechnology company developing treatments...
Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 5 hours agoIt is a pleasure to report that the vTv Therapeutics Inc. (NASDAQ:VTVT) is up 226% in the last...
4D Molecular Therapeutics Inc [FDMT] Insider Bizily Scott sells 1,750 Shares – Insider Selling Alert...
Knox Daily· 13 hours agoIn a filing, 4D Molecular Therapeutics Inc revealed its Chief Legal Officer Bizily Scott unloaded Company’s shares for reported $44541.0 on May 16 ’24. In the deal valued ...
Actuate Therapeutics Files for IPO
Market Watch· 3 days agoBy Dean Seal Actuate Therapeutics has filed for an initial public offering on the Nasdaq Capital Market. The clinical stage biopharmaceutical company said...
Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 8 hours agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
An Overview Of United Therapeutics Corp
Marketing Sentinel· 13 hours agoIn the last trading session, 0.36 million United Therapeutics Corp (NASDAQ:UTHR) shares changed hands as the company’s beta touched 0.49. With the company’s per share price ...
Allan Moss Buys 40% More Amplia Therapeutics Shares
Simply Wall St. via Yahoo Finance· 4 days agoInvestors who take an interest in Amplia Therapeutics Limited (ASX:ATX) should definitely note that insider Allan Moss recently paid AU$0.055 per share...
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 1 day agoViking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just...
Viking Therapeutics Inc [VKTX] Shares Fall
Knox Daily· 4 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Viking Therapeutics Inc shares valued at $4,986,008 were sold ...
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
WFRV 5 Green Bay· 20 hours agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech ...
